Homing to nonlymphoid tissues is not necessary for effector Th1 cell differentiation

被引:6
|
作者
Bajénoff, M [1 ]
Guerder, S [1 ]
机构
[1] Univ Mediterranee, CNRS, Inst Natl Sante & Rech Med, Ctr Immunol Marseille, F-13288 Marseille 09, France
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 12期
关键词
D O I
10.4049/jimmunol.171.12.6355
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The differentiation of naive T cells into effector Th1 cells is a complex process that may proceed in two steps, commitment and development. Initial TCR engagement and IFN-gamma signaling instruct the T cells to commit to the Th1 lineage, while subsequent IL-12 and potentially TCR signaling induces final differentiation into irreversible, Th1 effector cells. In agreement with a multistep process of Th1 cell differentiation, effector Th1 cell generation requires repeated TCR and cytokine signaling, thus raising the possibility that commitment and differentiation processes may occur in two distinct anatomical sites, the lymphoid organ and the site of infection, respectively. We tested this possibility using a model of skin sensitization that permits a direct analysis of Ag-specific T cells both within lymphoid organs and at the site of sensitization. We show in this study that Ag presentation in the skin does not induce further differentiation of skin-infiltrating T cells that are highly divided and fully differentiated effector cells. Thus, effector Th1 cell differentiation is completed within lymphoid organs. In addition, we examined the heterogeneity of CD4 T cell responses in vivo through the analysis of the expression, by activated T cells, of different selectins, including P-selectin ligand and CD62L known to define separable effector populations. We delineated, in lymph nodes, at least five distinct subpopulations of activated CD4 T cells with different phenotypes and recirculation properties. Collectively, these results show that the lymphoid environment orchestrates T cell activation to generate a repertoire of effector T cells with a diversity of effector functions.
引用
收藏
页码:6355 / 6362
页数:8
相关论文
共 50 条
  • [1] Inhibins/TGFβRIII modulate T cell activation and Th1/Th17 effector differentiation
    Soldevila, Gloria
    Ortega-Francisco, Sandra A.
    Morales, Alexandra
    Montes de Oca, Selina
    Albarran, Adrian
    Hernandez-Campos, Oscar
    Olguin-Alor, Roxana
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [2] Effector mechanisms of diabetogenic Th1 T cell clones
    Cantor, JM
    Haskins, K
    FASEB JOURNAL, 2003, 17 (07): : C271 - C272
  • [3] Lipopolysaccharide Potentiates Effector T Cell Accumulation into Nonlymphoid Tissues through TRIF
    McAleer, Jeremy P.
    Rossi, Robert J.
    Vella, Anthony T.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (09): : 5322 - 5330
  • [4] Instructing TH1/TH2-cell differentiation
    Elaine Bell
    Nature Reviews Immunology, 2004, 4 : 490 - 490
  • [5] Agonistic binding of neurokinin 1 receptor is necessary for the development of cutaneous effector Th1 and Th2 immunity
    Ho, C. H.
    Sumpter, T. L.
    Tkacheva, O. A.
    Shufesky, W. J.
    Morelli, A. E.
    Larregina, A. T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S11 - S11
  • [6] T CELL DIFFERENTIATION The TH1 two step
    Leavy, Olive
    NATURE REVIEWS IMMUNOLOGY, 2009, 9 (06) : 387 - 387
  • [7] Epigenetic control of human Th1 cell differentiation
    Letimier, Fabrice A.
    Passim, Nadia
    Gasparian, Sona
    Bianchi, Katar-Elisabetta
    Rogge, Lars
    CYTOKINE, 2007, 39 (01) : 23 - 23
  • [8] Th1/Th2 Cell Differentiation and Molecular Signals
    Zhang, Yuan
    Zhang, Yaguang
    Gu, Wangpeng
    Sun, Bing
    T HELPER CELL DIFFERENTIATION AND THEIR FUNCTION, 2014, 841 : 15 - 44
  • [9] T cell effector subsets: Extending the Th1/Th2 paradigm
    Chtanova, T
    Mackay, CR
    ADVANCES IN IMMUNOLOGY, VOL 78, 2001, 78 : 233 - 266
  • [10] P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlymphoid effector sites in the intestinal lamina propria
    Haddad, W
    Cooper, CJ
    Zhang, Z
    Brown, JB
    Zhu, YC
    Issekutz, A
    Fuss, I
    Lee, H
    Kansas, GS
    Barrett, TA
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (03): : 369 - 377